glp-1 and muscle loss Glucagon-like peptide-1 receptor agonists mass effects Study finds GLP-1 receptor agonists
Description
Retrieved from: NovoCare-a

doi: 10.1001/jama.2013.281361

PLoS ONE, 20 (4), e0326210

Alvarez E, Martnez MD, Roncero I, Chowen JA, Garca-Cuartero B, Gispert JD, et al

158,159 The AUC of S- and R-warfarin was not affected by dulaglutide and tirzepatide administration

Type 2 diabetes, pre-diabetes, cardiovascular history, PCOS, fatty liver, sleep apnoea, joint pain
